These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34572178)

  • 21. Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway.
    Verhoeven NM; Huck JH; Roos B; Struys EA; Salomons GS; Douwes AC; van der Knaap MS; Jakobs C
    Am J Hum Genet; 2001 May; 68(5):1086-92. PubMed ID: 11283793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypergonadotropic Hypogonadism Due to Transaldolase Deficiency: Two Cases and Literature Review.
    Takaleh A; Abunamous N; AlShamsi A; Alhassani N; Almazrouei R
    JCEM Case Rep; 2024 Mar; 2(3):luae028. PubMed ID: 38440129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of pretransplant hepatic encephalopathy, model for end-stage liver disease (MELD) scale on long-term survival following deceased donor liver transplantation: a retrospective study.
    Yoon JU; Yoo YM; Byeon GJ; Kim HJ; Choi EJ; Park S; Kim HY
    Ann Palliat Med; 2021 May; 10(5):5171-5180. PubMed ID: 33894716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
    Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
    Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transaldolase deficiency - clinical outcome, pathogenesis, diagnostic process].
    Lipiński P; Stradomska T; Tylki-Szymańska A
    Dev Period Med; 2018; 22(2):187-196. PubMed ID: 30056406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.
    Wang C; Guo K; Gao D; Kang X; Jiang K; Li Y; Sun L; Zhang S; Sun C; Liu X; Wu W; Yang P; Liu Y
    Cancer Lett; 2011 Dec; 313(2):154-66. PubMed ID: 22023829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver and kidney transplant in primary hyperoxaluria: a single center experience.
    Moray G; Tezcaner T; Özçay F; Baskın E; Akdur A; Kırnap M; Yıldırım S; Arslan G; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():145-7. PubMed ID: 25894144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.
    Lerut J; Iesari S; Vandeplas G; Fabbrizio T; Ackenine K; Núñez MEI; Komuta M; Coubeau L; Ciccarelli O; Bonaccorsi-Riani E
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):412-422. PubMed ID: 31521538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report.
    Peces R; Afonso S; Peces C; Nevado J; Selgas R
    BMC Med Genet; 2017 Aug; 18(1):97. PubMed ID: 28859624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
    Geyer ED; Burrier C; Tumin D; Hayes D; Black SM; Washburn WK; Tobias JD
    Transpl Int; 2018 Nov; 31(11):1200-1206. PubMed ID: 29907976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature.
    Schober S; Schilbach K; Doering M; Cabanillas Stanchi KM; Holzer U; Kasteleiner P; Schittenhelm J; Schaefer JF; Mueller I; Lang P; Handgretinger R
    BMC Pediatr; 2019 Oct; 19(1):346. PubMed ID: 31604460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver Transplantation in Polish Children With α
    Bakula A; Pawlowska J; Niewiadomska O; Jankowska I; Teisseyre M; Kaliciński P; Socha P
    Transplant Proc; 2016 Dec; 48(10):3323-3327. PubMed ID: 27931577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for hepatocellular carcinoma from living-donor
    Akamatsu N; Kokudo N
    Hepatobiliary Surg Nutr; 2016 Oct; 5(5):422-428. PubMed ID: 27826557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
    Chen LP; Li C; Wen TF; Yan LN; Li B; Yang JY
    Pak J Med Sci; 2015; 31(4):763-9. PubMed ID: 26430399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
    J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.